Plant-based ingredients provider, Roquette is offering visitors to its stand at CPhI a digital tour of the company's latest biopharmaceutical innovations.
digital drug
Roquette is at the show this week to present its range of newly launched products, including its low endotoxin Kleptose BioPharma for protein stability and Dextrose Anhydrous BioPharma for cell culture solutions.
The company states that these solutions support its commitment to helping customers save and sustain patient’s lives.
Visitors to the company’s booth (8F30) can find out about Roquette’s multi-compendial grade materials for both upstream and downstream biopharma applications.
The company has recently expanded its research & development and customer technical service teams to include facilities in Singapore’s Biopolis international research and develop centre.
More so, experts at the company’s booth are available to discuss Roquette’s recently acquired Microcrystalline Cellulose products and other leading excipients.